Afrah Fatthi Salama

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 18

Top Topics

Hydrogen Peroxide

Top Venues

Medical oncology (Northwood, London, England)

BMC microbiology

Naunyn-Schmiedeberg's archives of pharmacology

BMC complementary medicine and therapies

This page only lists publications with an associated author ORCID identifier.

Publications

Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Correction to: Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (5) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (2) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (2) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (2) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (2) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Correction to: Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (5) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (2) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (2) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (2) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (2) (2024)
Afrah Fatthi Salama, Ali H El-Far, Esraa Ali Anbar, Sabry Ali El-Naggar, Rami M Elshazli, Alaa Elmetwalli
Correction to: Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression. Medical oncology (Northwood, London, England) 41 (5) (2024)
Alaa Elmetwalli, Thoria Diab, Aisha Nawaf Albalawi, Sabry Ali El-Naggar, Ali H El-Far, Amira Radwan Ghedan, Eman Saad Alamri, Afrah Fatthi Salama
Diarylheptanoids/sorafenib as a potential anticancer combination against hepatocellular carcinoma: the p53/MMP9 axis of action. Naunyn-Schmiedeberg's archives of pharmacology (2023)
Alaa Elmetwalli, Nanis G Allam, Mervat G Hassan, Aisha Nawaf Albalawi, Azza Shalaby, Karim Samy El-Said, Afrah Fatthi Salama
Evaluation of Bacillus aryabhattai B8W22 peroxidase for phenol removal in waste water effluents. BMC microbiology 23 (1) (2023)
Tarek El-Sewedy, Afrah Fatthi Salama, Amro E Mohamed, Nashwa M Elbaioumy, Ali H El-Far, Aisha Nawaf Albalawi, Alaa Elmetwalli
Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death. BMC complementary medicine and therapies 23 (1) (2023)
Alaa Elmetwalli, Nanis G Allam, Mervat G Hassan, Aisha Nawaf Albalawi, Azza Shalaby, Karim Samy El-Said, Afrah Fatthi Salama
Evaluation of Bacillus aryabhattai B8W22 peroxidase for phenol removal in waste water effluents. BMC microbiology 23 (1) (2023)
Alaa Elmetwalli, Nanis G Allam, Mervat G Hassan, Aisha Nawaf Albalawi, Azza Shalaby, Karim Samy El-Said, Afrah Fatthi Salama
Evaluation of Bacillus aryabhattai B8W22 peroxidase for phenol removal in waste water effluents. BMC microbiology 23 (1) (2023)
Alaa Elmetwalli, Nanis G Allam, Mervat G Hassan, Aisha Nawaf Albalawi, Azza Shalaby, Karim Samy El-Said, Afrah Fatthi Salama
Evaluation of Bacillus aryabhattai B8W22 peroxidase for phenol removal in waste water effluents. BMC microbiology 23 (1) (2023)
Alaa Elmetwalli, Shimaa Mustafa Hashish, Mervat G Hassan, Mohammed Abu El-Magd, Sabry Ali El-Naggar, Amina M Tolba, Afrah Fatthi Salama
Modulation of the oxidative damage, inflammation, and apoptosis-related genes by dicinnamoyl-L-tartaric acid in liver cancer. Naunyn-Schmiedeberg's archives of pharmacology (2023)